{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:32:12Z","timestamp":1793295132517,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background and aims:<\/jats:bold> Pulmonary arterial hypertension (PAH) is a chronic pulmonary vascular disorder characterized by elevated pulmonary vascular resistance (PVR) and pulmonary arterial pressure (PAP). Right heart failure is a life-threatening complication of PAH and predicts a poor prognosis. PAH associated with congenital heart disease (PAH-CHD) and idiopathic PAH (IPAH) are two prevalent PAH subtypes in China. In this section, we set out to explore baseline right ventricular (RV) function and its response to targeted agents between IPAH and PAH-CHD.<\/jats:p><jats:p><jats:bold>Methods and results:<\/jats:bold> Consecutive patients diagnosed with IPAH or PAH-CHD by right heart catheterization (RHC) in the Second Xiangya Hospital from November 2011 to June 2020 were included. All patients received PAH-targeted therapy and the RV function was assessed by echocardiography at baseline and during follow-up. A total of 303 patients (age, 36.23 \u00b1 13.10\u00a0years; women, 213 (70.3%); mean PAP [mPAP], 63.54 \u00b1 16.12\u00a0mmHg; PVR, 14.74 \u00b1 7.61\u00a0WU) with IPAH (<jats:italic>n<\/jats:italic> = 121) or PAH-CHD (<jats:italic>n<\/jats:italic> = 182) were included in this study. Compared with PAH-CHD, patients with IPAH had worse baseline RV function. As of the latest follow-up, forty-nine patients with IPAH and six patients with PAH-CHD died. Kaplan-Meier analyses showed better survival in PAH-CHD versus IPAH. After PAH-targeted therapy, patients with IPAH had less improvement in 6\u00a0MWD, World Health Organization functional class, and RV functional parameters compared with patients with PAH-CHD.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Compared with patients with PAH-CHD, patients with IPAH had worse baseline RV function, unfavourable prognosis, and inadequate response to targeted treatment.<\/jats:p>","DOI":"10.3389\/fphar.2023.1124746","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T06:54:14Z","timestamp":1676271254000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD"],"prefix":"10.3389","volume":"14","author":[{"given":"Tengteng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1513\/AnnalsATS.201608-655OC","article-title":"Differences in right ventricular functional changes during treatment between systemic sclerosis-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension","volume":"14","author":"Argula","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.202009-3698OC","article-title":"Association between initial treatment strategy and Long-Term survival in pulmonary arterial hypertension","volume":"204","author":"Boucly","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/heartjnl-2017-312106","article-title":"Pulmonary arterial hypertension in adult congenital heart disease","volume":"104","author":"Brida","year":"2018","journal-title":"Heart"},{"key":"B4","doi-asserted-by":"publisher","first-page":"20458940211012366","DOI":"10.1177\/20458940211012366","article-title":"Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension","volume":"11","author":"Chandel","year":"2021","journal-title":"Pulm. Circ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: Identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1378\/chest.13-3014","article-title":"Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry","volume":"146","author":"Chung","year":"2014","journal-title":"Chest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1113\/JP279759","article-title":"New insights into resting and exertional right ventricular performance in the healthy heart through real-time pressure-volume analysis","volume":"598","author":"Cornwell","year":"2020","journal-title":"J. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann. Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.chest.2019.09.009","article-title":"Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension","volume":"157","author":"D'Alto","year":"2020","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-320526","article-title":"Right ventricular function across the spectrum of health and disease","author":"Edward","year":"2022","journal-title":"Heart"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5603\/ARM.2020.0071","article-title":"Differences in right ventricular dysfunction in patients with idiopathic pulmonary hypertension versus secondary pulmonary hypertension","volume":"88","author":"Emami","year":"2020","journal-title":"Adv. Respir. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1378\/chest.15-0300","article-title":"Five-Year outcomes of patients enrolled in the REVEAL Registry","volume":"148","author":"Farber","year":"2015","journal-title":"Chest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.pcad.2018.07.017","article-title":"A multifaceted approach to pulmonary hypertension in adults with congenital heart disease","volume":"61","author":"Fathallah","year":"2018","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1378\/chest.12-3033","article-title":"Pericardial effusions in pulmonary arterial hypertension: Characteristics, prognosis, and role of drainage","volume":"144","author":"Fenstad","year":"2013","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): Endorsed by: Association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur. Heart J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/echo.13112","article-title":"Is right ventricular remodeling in pulmonary hypertension dependent on etiology? An echocardiographic study","volume":"33","author":"Giusca","year":"2016","journal-title":"Echocardiography"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1136\/heartjnl-2021-320733","article-title":"Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response","volume":"108","author":"Goh","year":"2022","journal-title":"Heart"},{"key":"B18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","article-title":"Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry","volume":"168","author":"Hoeper","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"lancet Respir. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1161\/CIRCULATIONAHA.116.022082","article-title":"Right ventricular functional reserve in pulmonary arterial hypertension","volume":"133","author":"Hsu","year":"2016","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1161\/CIRCULATIONAHA.117.033147","article-title":"Right ventricular myofilament functional differences in humans with systemic Sclerosis-Associated versus idiopathic pulmonary arterial hypertension","volume":"137","author":"Hsu","year":"2018","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1161\/CIRCULATIONAHA.110.985515","article-title":"Sex and race differences in right ventricular structure and function: The multi-ethnic study of atherosclerosis-right ventricle study","volume":"123","author":"Kawut","year":"2011","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: A comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur. Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jcin.2021.12.020","article-title":"Catheterization in adults with Congenital\u00a0Heart disease: A\u00a0Primer\u00a0for\u00a0the\u00a0Noncongenital\u00a0Proceduralist","volume":"15","author":"Miranda","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: Recommendations from the American society of echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1183\/09031936.00135407","article-title":"Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension","volume":"31","author":"Overbeek","year":"2008","journal-title":"Eur. Respir. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.chest.2017.02.010","article-title":"Idiopathic and systemic sclerosis-associated pulmonary arterial hypertension: A comparison of demographic, hemodynamic, and mri characteristics and outcomes","volume":"152","author":"Ramjug","year":"2017","journal-title":"Chest"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/rccm.201507-1456OC","article-title":"Comparison of treatment response in idiopathic and connective tissue disease\u2013associated pulmonary arterial hypertension","volume":"192","author":"Rhee","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: A review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jacc.2018.12.076","article-title":"Anatomy, function, and dysfunction of\u00a0the Right\u00a0Ventricle: JACC state-of-the-art review","volume":"73","author":"Sanz","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cjca.2012.04.009","article-title":"Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension","volume":"29","author":"Shimony","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12968-020-00694-0","article-title":"Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension","volume":"23","author":"Sree","year":"2021","journal-title":"J. Cardiovasc Magn. Reson"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/cvr\/cvx159","article-title":"Role of cardiac inflammation in right ventricular failure","volume":"113","author":"Sun","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/CIRCHEARTFAILURE.112.000008","article-title":"Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension","volume":"6","author":"Tedford","year":"2013","journal-title":"Circ. Heart Fail"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e009047","DOI":"10.1161\/CIRCIMAGING.119.009047","article-title":"Validation of the tricuspid annular plane systolic Excursion\/Systolic pulmonary artery pressure ratio for the assessment of right Ventricular-Arterial coupling in severe pulmonary hypertension","volume":"12","author":"Tello","year":"2019","journal-title":"Circ. Cardiovasc Imaging"},{"key":"B37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1164\/rccm.202006-2147ED","article-title":"Pulmonary arterial hypertension and sex in the right ventricle: It is an interesting picture","volume":"202","author":"Thenappan","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.115.020696","article-title":"Bone morphogenetic protein receptor type 2 mutation in pulmonary arterial hypertension: A view on the right ventricle","volume":"133","author":"van der Bruggen","year":"2016","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/cvr\/cvx145","article-title":"RV pressure overload: From hypertrophy to failure","volume":"113","author":"van der Bruggen","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/eurheartj\/ehx034","article-title":"Pulmonary arterial hypertension in congenital heart disease: Translational opportunities to study the reversibility of pulmonary vascular disease","volume":"38","author":"van der Feen","year":"2017","journal-title":"Eur. Heart J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jcmg.2021.07.027","article-title":"The REPAIR study: Effects of macitentan on RV structure and function in pulmonary arterial hypertension","volume":"15","author":"Vonk","year":"2022","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1124746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T06:54:17Z","timestamp":1676271257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1124746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":41,"alternative-id":["10.3389\/fphar.2023.1124746"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1124746","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"article-number":"1124746"}}